Thyrocare Technologies Limited (Company) entered into a subscription agreement at Tanzania with Kastipharm Limited (Kastipharm) and other individuals on September 19, 2023 for setting up a joint venture company for the purpose of providing diagnostic and healthcare services to customers directly, through the laboratories that will be owned and operated by joint venture company or through third party laboratories in Tanzania. Name: Thyrocare Laboratories (Tanzania) Limited (JV Company). The JV Company will become a related party upon incorporation and first tranche of investment; and any future investments in the JV Company will be a related party transaction.

However, none of the promoters /promoter group /group companies have any interest in JV Company. JV Company will provide diagnostic and healthcare services to customers directly, through the laboratories that will be owned and operated by JV Company or through third party laboratories in Tanzania. The JV Company is incorporated as a part of long term business plans of the Company on expansion of Company's existing business of providing diagnostics services in different geographies.

Date of incorporation: September 19, 2023. Country of incorporation: Tanzania.